Gregory S. Ducker
Impact in
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- Clinical Biochemistry top 2%
- Metabolism and Genetic Disorders
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 9
- Epigenetics and DNA Methylation 6
- RNA modifications and cancer 4
- Biochemical and Molecular Research 3
-
- Cancer, Hypoxia, and Metabolism 5
- Co-authors
- Joshua D. Rabinowitz (10 shared papers)Raphael J. Morscher (2 shared papers)Kevan M. Shokat (10 shared papers)Jonathan M. Ghergurovich (3 shared papers)Xin Teng (2 shared papers)Li Chen (2 shared papers)Hsin‐Jung Li (2 shared papers)Zemer Gitai (2 shared papers)
- Journals
- Cell Metabolism (4 papers)Proceedings of the National Academy of Sciences (3 papers)Archives of Pathology & Laboratory Medicine (2 papers)JCI Insight (2 papers)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesAustriaUnited Kingdom
In The Last Decade
Gregory S. Ducker
27 papers receiving 3.2k citations
Gregory S. Ducker's Hit Papers
Peers
Comparison fields: 5 of 127
- Cancer Research 763
- Clinical Biochemistry 235
- Biochemistry 243
- Rheumatology 494
- Molecular Biology 2.1k
Countries citing papers authored by Gregory S. Ducker
This map shows the geographic impact of Gregory S. Ducker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory S. Ducker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory S. Ducker more than expected).
Fields of papers citing papers by Gregory S. Ducker
This network shows the impact of papers produced by Gregory S. Ducker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory S. Ducker. The network helps show where Gregory S. Ducker may publish in the future.
Co-authors
The 25 scholars most cited alongside Gregory S. Ducker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | One-Carbon Metabolism in Health and Disease Hit paper breakdown → | 2016 | 1400 |
| 2 | 2016 | 323 | |
| 3 | 2019 | 251 | |
| 4 | 2013 | 204 | |
| 5 | 2018 | 190 | |
| 6 | 2017 | 179 | |
| 7 | 2020 | 93 | |
| 8 | 2011 | 90 | |
| 9 | 2013 | 75 | |
| 10 | 2020 | 58 | |
| 11 | 2020 | 47 | |
| 12 | 2010 | 38 | |
| 13 | 2010 | 38 | |
| 14 | 2017 | 36 | |
| 15 | 2018 | 34 | |
| 16 | 2024 | 29 | |
| 17 | 2013 | 21 | |
| 18 | 2010 | 15 | |
| 19 | 2012 | 15 | |
| 20 | 2018 | 14 |
About Gregory S. Ducker
Gregory S. Ducker is a scholar working on Molecular Biology, Cancer Research, Oncology, Rheumatology and Hematology, having authored 29 papers that have together received 3.2k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (9 papers), Epigenetics and DNA Methylation (6 papers), Cancer, Hypoxia, and Metabolism (5 papers), Amino Acid Enzymes and Metabolism (4 papers), RNA modifications and cancer (4 papers), Metabolism and Genetic Disorders (3 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Biochemical and Molecular Research (3 papers). The work is most often cited by research in Cancer Research (763 citations), Clinical Biochemistry (235 citations), Biochemistry (243 citations), Rheumatology (494 citations) and Molecular Biology (2.1k citations). Gregory S. Ducker has collaborated with scholars based in United States, Austria and United Kingdom. Frequent co-authors include Joshua D. Rabinowitz, Raphael J. Morscher, Kevan M. Shokat, Jonathan M. Ghergurovich, Xin Teng, Li Chen, Hsin‐Jung Li, Zemer Gitai, Yibin Kang and Mark Esposito. Their work appears in journals such as Cell Metabolism, Proceedings of the National Academy of Sciences, Archives of Pathology & Laboratory Medicine, JCI Insight and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.